Idrinol a i Mildronate, ʻoi aku ka maikaʻi?

• 8 Malaki 2016: Ua hoʻolaha ʻia ʻo Maria Sharapova, ʻo ke kolone mua o ka honua, i ka wā o ka ʻaha kūkā ma Los Angeles ʻaʻole ia i hele i ka hoʻokolohua doping ma Australia ma muli o ka loaʻa o ka meldonium. ʻLelo aku ʻo ia ua hoʻohana ʻo ia i ka lāʻau Mildronate no nā makahiki he ʻumi ma muli o nā pilikia olakino (ua kuhikuhi ʻia ʻo ia e kekahi kauka ʻohana) akā ua hala i ka manawa i pāpā ʻia ai ka meldonium. Ua haʻalele ʻia ʻo Maria Sharapova no ʻelua makahiki. Hoʻopau ʻia ka pāpā i ka lā 26 Ianuali 2016. Ma ka lā like loa, ua hoʻolaha ka mea hoʻokūkū Lūkini ʻo Yekaterina Bobrova (ka hula hula ma ka hau) he hoʻomaʻamaʻa maikaʻi loa no ka meldonium.
• ʻO ka hoa holo waena Sweden o Ababa Aregavi, ʻo Turaba Aregavi, ka Turakūlima ma waena iho nei ʻo Gamze Bulut, ka mea hoʻokūkū lōʻihi o Indisho Negesse, ka mea hoʻokauwā Lūkia ʻo Eduard Vorganov, biathletes Ukrania Olga Abramova a me Artem Tishchenko, ua hoʻoleʻemae iki ʻia no ka hoʻohana ʻana i meldonium.
• 8 Malaki: ua ʻike ʻia ʻo Semyon Elistratov e hele i ka World Short Track Championship ma muli o kahi hoʻokolohua kūpono no ka meldonium. Ua loaʻa nō hoʻi ʻo Meldonium i kahi hoʻohālike o ke skater ʻo Pavel Kulizhnikov a me ka mea hoʻokani pila volleyball ʻo Alexander Markin.
• Ma Malaki 9: ua lohi ʻia ka biathlete Eduard Latypov mai ka komo ʻana i ka hoʻokūkū; ua loaʻa i ka meldonium i kahi hōʻike doping me Ekaterina Konstantinova (ala pōkole).
• 10 Malaki: Ua ʻōlelo ʻo WADA, ʻo Craig Ridi, inā he lohi loa ʻo ia i ka hoʻopaʻapaʻa ʻana iā Maria Sharapova, manaʻo ko kāna hui e hoʻopiʻi i ka Hale Hoʻokolokolo o ʻAlezalau no Sport.
• 11 Malaki: ua hoʻolaha ʻo WADA, ua hoʻāʻo ʻo 60 mau mea hoʻokūkū no ka meldonium.
• Ma Malaki 11: Na ke Kōmike ʻo Duma i ka Palakiko i mālama i kahi hālāwai e kūkākūkā ai no ka hāpai ʻana i ka bila doping a me ke kūlana me ka hoʻohana ʻana o meldonium ma waena o nā mea pāʻani ma hope o ka pāpā ʻana i kona hoʻohana.
• 12 Malaki: Ua ʻōlelo ʻo Kuhina Kuhina Nui o ke Aupuni Lūkini ʻo Arkady Dvorkovich e noi ʻia nā hopena o ke ʻano meldonium e noi ʻia mai WADA.
• Ma Malaki 14: Ke noi a ke Keʻena o ka Sports Sports o ka Lūkini Russian i nā hopena o kahi noiʻi ʻepekema ʻo meldonium mai WADA.
• Pōʻalua 14: Ua ʻōlelo ʻo Craig Reedy e haʻalele mai ʻo WADA i ka meldonium mai ka papa inoa o nā lāʻau lapaʻau i pāpā ʻia.
• 15 Malaki: Ua hoʻokō ʻo UN i ke kūlana luna wahine punahele Maria Sharapova a me ka hoʻokolokolo ʻana.
• Ma ka lā 17 Malaki: ua paʻa ʻo ke kai lawehala ʻo Julia Efimova i ke komo ʻana i ka hoʻokūkū ma muli o ka hiki ke hoʻokahakena i nā kānāwai anti-doping.
• Ma ka lā Malaki 20: loaʻa nā meldonium i nā kiʻi doping i lawe ʻia ma ka ʻāpana o ka hoʻokūkū Lūkini Lūkini mai nā mea pāʻani Nadezhda Kotlyarova, Andrei Minzhulin, Gulshat Fazletdinova a me Olga Vovk.
• ʻO Malaki 22: loaʻa i ka meldonium i nā hoʻokolilo doping o nā kenekulia Ruska Greco-Romana ma kahi o ka poʻe Sergei Semenov a me Evgeny Saleev.
• Malaki 30: Ua ʻike ʻia ʻo Meldonium ma Alexei Bugaychuk, he mea hoʻokahukū doping o ka hui aupuni Lūkini.
• ʻApelila 2: ʻO ka mea kalaka ʻo Pavel Kulikov, ka mea i ʻike ʻia e hoʻohana ana i ka meldonium, ua kākau ʻia i loko o kahi leka i ke Kuhina Palakiko o Russian Federation V. Mutko ua pāpā aku ʻo WADA i kēia lāʻau lapaʻau wale nō ma muli o kona kaulana i waena o nā mea pāʻani mai nā ʻāina CIS.
• ʻO ʻApelila 3: hōʻike doping hōʻike ʻo ka poʻokela o Lūkini i ke gymnastics Nikolai Kuksenkova i hāʻawi i kahi hopena kūpono no ka meldonium. Wahi a Valentin Rodionenko, alakaʻi mua o ka hui kalapuʻāina ʻo Lūkini, a hiki i ka ʻAukake 1, 2015, ua loaʻa ka meldonium ma o ka Federal Medical and Biological Agency a me nā mea hoʻokūkū o nā hui āpau i ʻae iā ia.
• ʻApelila 8: Ua hōʻoia ka Russian Hockey Federation e hōʻike ana i ka hoʻokumu ʻana o ka hui o ka hui kī hau hau a Lūkini ma ka 2016 World Cup ma hope o ka loaʻa ʻana o ka poʻe meldonium i loko o nā hoʻokolohua doping.
• ʻO ʻApelila 11: test doping Ua loaʻa i kahi poʻokela maʻEulopa i ka makahikiʻehā o Igor Mikhalkin kahi hopena maikaʻi no ka meldonium.
• ʻApelila 13: Ua ʻōlelo ʻia ʻo WADA, kahi mea paʻa o ka 1 microgram o ka meldonium i loko o ka hōʻike doping a ka mea hoʻokūkū, i waiho ʻia ma mua o Malaki 1, 2016, ke ʻae ʻia.
• Mei 13: I loko o kahi hoʻokolohua hōkā o ka pahu pahu kaumaha o ka Lūkini Alexander Povetkin, i lawe ʻia ma ʻApelila, ua loaʻa nā mea i koe o ke meldonium i loko o kahi paʻa o nā nan Nanam e 72. ʻAʻole hoʻoholo ka World Boxing Council e hoʻopau i ka hakakā ma waena o Povetkin a me American Deontay Wilder. Ma ka Mei 31, 2016, ua hoʻopuka ʻia ka hopena o ka hōʻike hou ʻelima no ka hōʻike doping i lawe ʻia mai Povetkin ma Mei 17, ka mea i hōʻike i ka hopena maikaʻi, i paʻi ʻia.
• Iulai 1: Ua manaʻo ʻo WADA i hiki ke ʻike i ka meldonium i loko o nā mau hoʻohālike ma mua o Kepakemapa 30, 2016 inā he haʻahaʻa o ka meldonium i loko o ke koko ma mua o 1 microgram no ka milliliter.
• I ka Malaki 2017, ua nīnau ka FMBA iā WADA i ka nīnau no ka wehe ʻana i ka meldonium mai ka papa inoa o nā lāʻau lapaʻau i pāpā ʻia. "Ua hoʻopaʻa inoa wau a WADA i kahi protocol e hoʻopaʻa i nā huahana pharmacokinetic o meldonium. Ma ʻApelila o kēia makahiki, loaʻa kahi kūkākūkā e pili ana i ka hoʻokō o ka protocol, "wahi a Vladimir Uyba, ke poʻo o ka FMBA ma kahi kūkā nūpepa.
• Ma Pepeluali 18, 2018, ʻaʻole i hele ka mea hoʻokūkū curling ʻo Alexander Krushelnitsky i ka hōʻike doping ma ka hoʻoilo ʻana o ka hoʻoilo ma ka hoʻoilo ma ka hoʻoilo o Winter Winter ma Pyeongchang, ma kāna kiʻi, ua loaʻa ka meldonium. Ma hope o ka hoʻokolohua hoʻohālikelike B, nāna i hōʻoia i ka hiki ʻana o nā ʻāpana o ka hoʻohana ʻana o ka meldonium i loko o ke kino o Krushelnitsky, ua hoʻoneʻe ka ʻokoʻa i ka ʻAha Kūkākūkā o ʻAmelika iā ia i kahi pine Olena.

1. ↑Sigma-Aldrich.Meldonium dihydrate (English).
2. ↑ Ke kauoha a ke Aupuni o ka Lūkini Lūkini i ka lā 7 Dekemaba, 2011 N 2199-r(unuhi ʻole ʻia) (html). RG - Nā Iāpana Federal Federal 5660 (284). ^ E Ha yM. Moscow: Lākana Lūkini (16 Dekemaba 2011). ʻO ka lā mālama no Ianuali 6, 2012.
3. ↑ kahi hale kūʻai e kūʻai aku ai i ka lāʻau lapaʻau ma luna aʻe. Hale kūʻai Meldonium. ʻOi ka lā hoʻopiʻi 25 ʻOkakopa, 2017.
4. ↑ 1234Eremeev A. et al.3- (2,2,2-Trimethylhydrazinium) hāʻawi i ka hana a me ke ʻano no ka hoʻomākaukau a me ka hoʻohana. Patent US 4481218 A (English) (11/6/1984).
5. ↑Daria Grigorova.Ua kapa ʻia ka mea hoʻokumu o ka meldonium i ʻelua mau kumu no ka hoʻoholo o WADA(unuhi ʻole ʻia) . ^ E Ha yM. Vesti.Ru (8 Malaki 2016). ʻO ka lā mālama no Malaki 19, 2016.
6. ↑ 1234Radio Liberty.Ua'ōlelo ʻo Meldonius(unuhi ʻole ʻia) (Maraki 13, 2016).
7. ↑ Meldonium (Mildronate) a i ʻole ka launa mai WADA!(unuhi ʻole ʻia) . ^ E Ha yM. www.buildbody.org.ua. ʻO ka lā mālama no Ianuali 18, 2017.
8. ↑ 12Kalvinsh I. et al.Meldonium paʻakai, ke ʻano o kā lākou hoʻomākaukau a me ka hoʻolālā lāʻau lapaʻau ma kā lākou kumu. Patent WO 2005012233 A1 (English) (02.10.2005).
9. ↑ Grigat S, Fork C, Bach M, Golz S, Geerts A, Schömig E, Gründemann D. ʻO ka mea lawe carnitine transporter SLC22A5 ʻaʻole ia ka mea lawe molowa maʻamau, akā hoʻopuka maikaʻi i ka mildronate
10. ↑ Carnitine Metabolism and Human Nutritation, p.64
11. ↑ J, Moritz KU, Meissner K, Rosskopf D, Eckel L, Bohm M, Jedlitschky G, Kroemer HK. Hōʻalo i nā lāʻau cardiovascular i ka naʻau o ke kanaka: Hōʻike, hoʻoponopono, a me ka hana o ke carnitine transporter OCTN2 (SLC22A5). Kaʻi 2006,113: 1114-1122.
12. ↑ 12345Meldonium (Meldonium): aʻo, noi a me nā ʻano(unuhi ʻole ʻia) .
13. ↑Görgens C., Guddat S., Dib J., Geyer H., Schänzer W., Thevis M.ʻO Mildronate (Meldonium) i ka hana hoʻokani pīhoihoi - ka nānā ʻana i ka wai hoʻomalu i ka wai hoʻokeo e hoʻohana ai i ka wai hoʻohaʻahaʻa hydrophilic wai ((Eng.) // Kaʻi ʻana i ka lāʻau hoʻāʻo a me ka loiloi. - 2015. - Vol. 7, ʻaʻole. 11-12. - P. 973-979. - DOI: 10.1002 / dta.1788. - PMID 25847280.
14. ↑Dambrova Maija, Makrecka-Kuka Marina, Vilskersts Reinis, Makarova Elina, Kuka Janis, Liepinsh EdgarsNā hopena lāʻau lapaʻau o ka meldonium: ʻO nā hana biochemical a me nā biomarkers o nā hana cardiometabolic // ʻo ka mea noiʻi Pharmacological Research. - 2016. - Novemaba (t. 113). - S. 771-780. - ISSN1043-6618. - DOI: 10.1016 / j.phrs.2016.01.01.019. hoʻoponopono
15. ↑Nikolajs Sjakste, Aleksandrs Gutcaits, Ivars Kalvinsh.Mildronate: kahi lāʻau lapaʻau antiischemic no nā hōʻike neurological // nā loiloi CNS lapaʻau. - 2005-01-01. - T. 11, no. 2. - S. 151–168. - ISSN1080-563X.
16. ↑ 12Meldonium (Meldonium). ke aʻo ʻana, ka noi a me ke ʻano(unuhi ʻole ʻia). Radar // rlsnet.ru.Ka lā lapaʻau lā Malaki 9, 2016.
17. ↑ World anti-doping code international list dilali list. Ianuali 2016
18. ↑ WADA: 1 ka hoʻokaumaha o ka microgram o ka meldonium i loko o ka ʻike hoʻokolohua e pono ai, sports.ru, ʻApelila 13, 2016
19. ↑ʻO nā mea pili i hoʻopili. ^ E Ha yM. Hoʻopau ka WADA i ka papa inoa o nā mea i pāpā ʻia, USA I kēia lā (30 Kepakemapa 2015). Ka lā lapaʻau lā Malaki 7, 2016.
20. ↑ Hoʻolālā ʻinglelo WADA 2015(unuhi ʻole ʻia) . wada-ama.org. ^ E Ha yM. WADA (1 Ianuali 2016).
21. ↑ Mea hana: Hōʻalo i ka meldonium mai ke kino ke hiki i kekahi mau mahina, TASS, Malaki 21, 2016.
22. ↑ ʻO nā manawa hemo mai ka meldonium mai ke kino a hiki i ka ʻeono mahina
23. ↑Görgens C., Guddat S., Dib J., Geyer H., Schänzer W., Thevis M.ʻO Mildronate (Meldonium) i ka hana hoʻokani pīhoihoi - ka nānā ʻana i ka wai hoʻomalu i ka wai hoʻokeo e hoʻohana ai i ka wai hoʻohaʻahaʻa hydrophilic wai ((Eng.) // Kaʻi ʻana i ka lāʻau hoʻāʻo a me ka loiloi. - 2015. - Vol. 7, ʻaʻole. 11-12. - P. 973-979. - DOI: 10.1002 / dta.1788. - PMID 25847280.

Ma lalo o nā ʻano haʻuki-ʻokoʻa, ua hōʻike ʻia nā hōʻike e pili ana i nā hopena maikaʻi i ka hiki ke hana kino o nā mea hoʻokūkū elite i paʻi ʻia a me nā kaila o Mildronate (ma waena o 0.25 a me 1.0 g ʻelua mau lā i ka lā 2 mau hebedoma i ka wā hoʻomaʻamaʻa a me 10-14 lā ma mua hoʻokūkū) ke kūkākūkā ʻia. Ua hōʻike hou ʻia nā haʻawina hou i ka hoʻonui ʻana i ka hana hoʻomanawanui o nā mea hoʻokūkū, hoʻomaikaʻi hou i ka hoʻihoʻi ʻana ma hope o ka hoʻomaʻamaʻa ʻana, ka pale ʻana i ke kūpū, a me nā hana hou o nā pūnaehana neʻe waena (CNS). Eia kekahi, hōʻike ʻo Mildronate i nā hopena e hoʻomaikaʻi ana i ka hana a me ka hoʻonui ʻana i ka hana a me ka hana hoʻomanaʻo, ʻo ia hoʻi nā waiwai nā mea e hoʻomaʻamaʻa ʻia.

ʻO ia nā mea hoʻohālike ʻo Mildronate a me Idrinol?

ʻO Mildronate a me Idrinol - nā lāʻau i hoʻohana ʻia e mālama ai i ka ischemia (nele i ka oxygen) o ka puʻuwai, me nā ukana he nui (i loko o ka haʻuki), ua hoʻohui ʻia i ka lāʻau maʻamau no nā maʻi e pili ana i ka puni koko.
ʻO Idrinol a me Mildronate i like ka like me ka mea like - meldonium, ʻo ia hoʻi, hiki iā mākou ke ʻōlelo he hoʻokahi kēia ʻāpana like i hoʻoili ʻia ma lalo o nā inoa like ʻole. No laila, ʻo Mildronate a me Idrinol he mau huahana (nā lāʻau me nā mea kanu like, nā hōʻailona like, nā contraindications, nā hopena ʻaoʻao), a ʻaʻole nā ​​analogues (nā ʻikena ʻano like ʻole, akā nā hōʻailona like). Ka mea, no kēia mau hoʻomākaukau e loaʻa nā mea hoʻohālike e like, e like me: Mexidol, Riboxin, L - Carnitine.

E hoʻokuʻu i ke ʻano

Idrinol i ke ʻano o nā kapsul e loaʻa wale nō ma 250 mg, 40 mau ʻāpana.
ʻO Idrinol i nā ampoules he 10%, 5 ml i paʻi ʻia ma 5, a he 10 mau ʻāpana i kēlā me kēia, ʻoiaiʻo Mildronta e hana ʻia ana ma ampoules wale ma loko o 10 mau ʻāpana.

Loaʻa ka Mildronate i loko o ka pahu capsule ma 250 mg, 40 mau ʻāpana, a me 500 mg, 60 mau ʻāpana.

ʻAlaʻai Idrinol 100 mg / ml, 5 ml, 10 mau pā. - 314 mau rubles.
ʻAlaʻai Idrinol 100 mg / ml, 5 ml, 5 mau pcs. - 172 mau rubles.
Iyona Idrinol 250 mg papa, 40 pcs. - 163 mau rubles.

ʻO nā miloule Mildronate 10%, 5 ml, 10 mau pā. - 374 mau rubles.
Nā pahu mildronate i 500 500, 60 mau pcs. - 627 mau rubles.
Nā pahu mildronate 250 mg, 40 pcs. - 300 mau rubles.

Ua aneaneʻo Mildronate ma mua o 2 mau manawa.

He aha ka mea maikaʻi idrinol a i ʻole Mildronate?

Inā makemake ʻoe i ka lāʻau lapaʻau ʻoi aku ka maikaʻi ma mua o Idrinol a ʻo Mildronate, ʻaʻole ʻoe e loaʻa kahi pane mai ka mea ʻē aʻe. ʻAʻole loa ʻoe e loaʻa i kahi pane pākuʻi a i ʻole kekahi i ʻike i ka hoʻohana ʻana i nā lāʻau ʻelua, no ka mea like me ke ʻano ikaika o nā ʻano lāʻau i ka meldonium, ma ka hoʻoilo like. ʻO Unambiguously, hiki iā mākou ke ʻōlelo wale i ka mea maikaʻi i ke kumukūʻai, ka mea i ʻoi aku o ka maikaʻi.

Ma ke kumukūʻai maikaʻi, kokoke ʻo Idrinol i 2 mau manawa a ʻoi aku hoʻi.

ʻOi aku ka maikaʻi o Mildronate i ka maikaʻi, e like me ka mea i hoʻopiʻi ʻia ma Latvia ma lalo o ka mana hoʻomalu o ka Europa.

ʻO Cardionate a i Idrinol a i Mildronate kahi maikaʻi?

Nā pākeke Cardionate 250 mg, 40 ʻāpana - 186 mau rubles.
Initanua cardionate 100 mg / ml 5 ml ampoules 10 mau ʻāpana - 270 mau rubles.

ʻAlaʻai Idrinol 100 mg / ml, 5 ml, 10 mau pā. - 314 mau rubles.
ʻAlaʻai Idrinol 100 mg / ml, 5 ml, 5 mau pcs. - 172 mau rubles.
Iyona Idrinol 250 mg papa, 40 pcs. - 163 mau rubles.

ʻO nā miloule Mildronate 10%, 5 ml, 10 mau pā. - 374 mau rubles.
Nā pahu mildronate i 500 500, 60 mau pcs. - 627 mau rubles.
Nā pahu mildronate 250 mg, 40 pcs. - 300 mau rubles.

ʻO Mildronate, Cardionate, Idrinol - he mea lapaʻau kēia mau lāʻau (he mau generics lākou), Cardionate a me Idrinol e hana ʻia ma Rusia, a me Mildronate ma Latvia. ʻO Idrinol ka uku nui loa o kēia mau lāʻau - 250mg capsules, 40 ʻāpana - 163 rubles.

Ma muli o kēia, inā hilahila ʻoe e hana ʻia ana ʻo Idrinol ma Rūsia, a ʻo ke kumukūʻai o Idrinol ua kānalua ia, a laila ʻaʻole hopohopo, ʻoi aku ka maikaʻi o ke kūʻai aku i nā lāʻau lapaʻau ʻenemi maikaʻi loa o ʻAmelika - Mildronate.
Inā ʻaʻole ʻoe e ʻīwili ʻia e ka maikaʻi o ka hoʻomākaukau ʻana no ka home, a ʻaʻole hoʻi ʻoe makemake e overpay no kahi mea ʻEulopa, a laila, ʻoiaʻiʻo, ʻo ke koho maikaʻi loa no ʻoe e kūʻai mai iā Idrinol a i ʻole Cardionate.

Ka hōʻailona o nā lāʻau lapaʻau

E koho i kahi lāʻau lapaʻau, pono ʻoe e ʻike i kāna ʻano kumu.

ʻO kēia kahi kuhi metabolic e kōkua ai i ka hoʻoneʻeneʻana i ka ikehu o ka ikehu o nā pehu e hana ana i ka ischemia a i ʻole hypoxia. Ka puka helu - ka hopena no ka inikini (no ka hoʻokele intravenous a me ka intramuscular) a me nā capsules. Ma ke ʻano o nā papa, ʻaʻole i hoʻokuʻu ʻia ʻo Meldonium. ʻO ka pūnaehana o ka lāʻau lapaʻau ka komo pū ʻana o ka hana ikaika - meldonium dihydrate., ʻO ia ka mea kikoʻī i hoʻoili ʻia o ka gamma-butyrobetaine. ʻAʻole ia e ʻae i nā momona momona unoxidized e hōʻiliʻili i loko o nā pehu a hōʻemi i ke kāpili ʻana o carnitine.

Aia nā ʻāpana o Meldonium:

• ho'ēmi i nā hōʻike o ka noʻonoʻo a me ke kino,
• hoʻonui i ka hana kino
• pili i ka cellular metabolism,
• hoonui ka metabolism me ka hoʻemi ʻia o ke kahe koko a i ʻole nele o ka oxygen,
• hoʻohaʻahaʻa i ke kō
• Kākoʻo i nā hana hoʻokalakupua i ka naʻau,
• me ka ischemia e hoʻomaikaʻi i ke kahe koko ma ka wahi i hoʻopili ʻia,
• hoʻololo i ke kaʻina o ka nekrosis.

Mahalo i kēia meahana, lilo ke kanaka i ikaika hou, hoʻomaikaʻi i ka sirkebral, e hoʻomaʻamaʻa maʻalahi ke kino o ka oxygen. Ka ʻike nui loa o ka māhele nui i loko o ke koko e ʻike ʻia i nā hola 1-2 ma hope o ka hoʻokele intravenous o ka lāʻau a i ʻole ka capsule. Hoʻomaʻa ʻia ka lāʻau lapaʻau i nā pilikia o ka hoʻonaninani somatic a me autonomic i ka wā o ka haʻalele i loko o nā mea maʻi me ka waiʻona maʻi.

Nā hōʻailona no ka hoʻohana ʻana:

• maʻi ʻeha coronary (myocardial infarction, angina pectoris),
• cardiomyopathy (ma ke ʻano o ka hoʻohui paʻakikī),
• nāwaliwali o ka puʻuwai
• haʻalele pale
• ka huʻeha a me ke kaumaha cerebrovascular disorders (stroke, cerebrovascular insufficiency),
• hoʻokaumaha a me ke kino kino (me nā mea hoʻokūkī)
• ho'ēmi ʻia ka hana.

Nā hōʻailona no ka hoʻohana ʻana o Meldonium: maʻi maʻi coronary (myocardial infarction, angina pectoris).

E like me ka ʻāpana o ka lāʻau paʻakikī, ua hoʻohana ʻia nā inikini Meldonium no ka hemorrhage retinal, hemophthalmia, thrombosis retin ain retinal, retinopathy. Hāʻawi ʻia nā Capsules i ka manawa hoʻoponopono ma hope o ka hoʻokō ʻana. Me ka maʻi o ka maʻi maʻi, kauoha ʻia ka lāʻau e lawe i ke kakahiaka.

• mahuahua i ka naʻau intracranial i kumu i ka nā lolo tumed a me ka puka mai o ke kaumaha i waho.
• hapai
• umauma umauma,
• makahiki i 18 makahiki
• hypersensitivity i nā ʻāpana o ka lāʻau.

Me ka mālama aka, pono e hoʻohana ʻia ka lāʻau e nā poʻe me ka maʻi aʻeha i nā maʻi a i ʻole aʻokiʻoki.

I kekahi manawa ke lawe aku nei ʻo Meldonium i ka hoʻomohala ʻana o nā hopena ʻaoʻao penei:

• hōʻike kūmole
• tachycardia
• hoʻemi a hoʻonui paha i ke koko,
• psychomotor agitation,
• nāwaliwali laulā
• eosinophilia
• angioedema,
• kaʻiliʻili
• ʻulaʻulaʻula o ka ʻili,
• ʻili ka ʻili.

Mai Ianuali 1, 2016, ua kālai ʻia ʻo Meldonium i nā mea pāʻani ma nā palani haʻuki. Inā i ʻike ʻia ma kahi hoʻokolohua doping, ʻo ka World Anti-Doping Agency e hoʻohemo i kahi mea hoʻokani pila.

He huahana maikaʻi kēia e hoʻomaikaʻi i ke kinohona a me ka lako o nā kiko. ʻO ke ʻano o ka lāʻau lapaʻau ka hopena ʻoluʻolu polū no ka hoʻonā a me nā kapula gelatin keʻokeʻo. ʻO ka hana mana he meldonium dihydrate, e hoʻomaikaʻi ai i ka hana metabolism, ke kāpae i nā toxins i hōʻiliʻili ʻia mai nā pūpuna, nā leo a me ke pale aku i nā pūpū mai i nā ʻino. Ke hoʻohana nei iā Mildronate, e hiki i ke kanaka ke kū i nā ukana kaumaha a hoʻomaikaʻi hou ma hope o ia.

Ke hoʻohana nei iā Mildronate, e hiki i ke kanaka ke kū i nā ukana kaumaha a hoʻomaikaʻi hou ma hope o ia.

Hoʻonui ka lāʻau lapaʻau i ka hāʻawi ʻana i ke koko i ka lolo a kōkua i ka mālama ʻana i nā ʻano like ʻole o ka ʻōnaehana cardiovascular. Me ka hāʻuleʻole o ka puʻuwai, hoʻonui ka lāʻau lapaʻau i ka contractility o ka puʻuwai naʻau a hōʻemi i ka nui o ka hoʻouka ʻana o angina. I ka hihia o ka ulia cerebrovascular ischemic, hoʻomaʻamaʻa ka lāʻau lapaʻau i ke kahe koko i ka neʻe i ka ischemia. Eia kekahi, kōkua ʻo Mildronate i nā pilikia o ka ʻōnaehana a me ka maʻi o ka waihona kālā.

Nā hōʻailona no ka hoʻohana ʻana:

• maʻi maʻi coronary
• ʻinalelo angina pectoris
• myocardial infarction
• cardiomyopathy plg,
• puʻuwai paʻakikī
• māhā
• lawa hemahema,
• ka hoʻokaumaha kino
• heminal heminal,
• hemopaima,
• retinopathy
• hoʻemi ʻia ka hana
• haʻalele pale
• he hoʻonāukiuki o ka uaua retinal kikowaena.

Pākuʻi ʻia nā maʻi:

• makahiki i 18 makahiki
• hypersensitivity i nā ʻāpana o ka huahana,
• hoonui ae la,
• hapai
• ka wā aloha.

Me ka mālama aka, pono e lawe ʻia ʻo Mildronate e nā kānaka me ka maʻi ʻeha a i ʻole aʻokiʻoki. Ma ka maʻi diabetes, ua mālama ʻia i ke kakahiaka.

ʻO kahi lāʻau hōʻemi haʻahaʻa-mea ia e hoʻonā ʻole ai i ka hopena kino. Kūpono loa nā hanana ʻino loa.

• tachycardia
• nā ʻokoʻa koko
• psychomotor agitation,
• nā hōʻailona dyspeptic
• maʻi kūlohelohe i ke ʻano o ka ʻeha o ka ʻili, ʻulaʻula, nā ʻalā, ka mea nui.

Hoʻohālikelike o Meldonium a me Mildronate

I mea e ʻike ai i ka lāʻau ʻoi aku ka ikaika hou, pono ʻoe e hoʻohālikelike iā lākou.

ʻO ka Meldonium a me Mildronate kekahi mau hiʻohiʻona like:

• ʻo ka mea like i ka meldonium dihydrate,
• nā hōʻailona like, contraindications a me nā hopena ʻaoʻao,
• nā mea hana o nā lāʻau ʻelua - V> ʻokoʻa nā mea like

Kūlike nā lāʻau lapaʻau i ka nui o ka hapa nui. Hoʻohana ʻia ka Mildronate i loko o kahi waihona ʻo 500 mg, Meldonium - 250 mg.

Hoʻohui ʻia Idrinol

Hoʻohana ʻia ka hoʻohana ʻana o ka Idrinol ma ke ʻano he kanaka e pili ana i ka mālama ʻana i kekahi o nā pilikia o ka maʻi a me ka pilikia nekau, nā kūlana me ka hoʻoiho o ka hana.

No nā maʻi piipuni like ʻole, ʻo ka mea ikaika o ka lāʻau lapaʻau e kāpae i ka hopena o ischemia ma o ka hoʻihoʻi ʻana i ke kaulike ma waena o ka hoʻolako o ka oxygen i ka kiko a me kona hoʻohana ʻana i nā mea puna. Ua loaʻa ka hopena ikaika i ka hopena vasodilating.Eia kekahi, hoʻonui ia i ka wikiwiki o nā kaʻina metabolic a pale i ka hoʻokumu ʻana o nā pāla i nā paia o nā kīʻaha koko, e hōʻemi ana i ka hopena o ka atherosclerosis.

Hāʻawi ka māhele nui i ka normalization o ka ʻōpū o ke puʻuwai, no laila, e hōʻemi i ka nui o ka hoʻouka ʻana a angina a hoʻonui i ke kala ʻana i ke kino i ke kaumaha.

Ma ka hoʻomaʻamaʻa lāʻau maʻamau, ua kuhikuhi ʻia kahi lāʻau lapaʻau e hoʻonui i ka hiki i ke kino ke hoʻomanawanui i ka pilikia o ka noʻonoʻo. Ma hope o ka hoʻopuka ʻana, e hoʻomaikaʻi ka nānāʻana, hoʻonui i ka hana. Hoʻomaopopo ʻia ka lāʻau lapaʻau no ka hoʻoponopono hou ʻana o nā mea maʻi ma hope o ka hana ʻana. Mālama i ka pono i ka kaʻina hana. Eia kekahi, ʻo ka lawe ʻana iā Idrinol e kōkua i ka hōʻemi o ka manawa hoʻoponopono.

ʻAʻole hiki iā ʻoe ke hoʻohana i ka lāʻau lapaʻau ma ka mālama ʻana i nā mea maʻi me ka hypersensitivity pilikino i nā mea ikaika a hoʻohui. Hoʻopili ʻia ka hoʻohana ʻia ʻana o ka lāʻau i mua o ka hoʻonui ʻia ʻana o ka paʻakai intracranial i ka mea maʻi. ʻAʻole kuhikuhi ʻia ke koho ʻana iā Idrinol ma ke kaʻe ʻana o ka maʻi o intracranial a me nā kiʻi hewa ʻana o ka laha o ka venous. Mai kuhikuhi i ka lāʻau lapaʻau i nā mea maʻi ma lalo o ka 18 mau makahiki o ka wahine a me nā wahine hāpai.

I nā hanana pinepine, hiki ke ʻike ʻia nā hopena maikaʻi ʻole.

• hoowahawaha ana, haanui, palaualelo,
• psychomotor agitation,
• hoʻonui i ke koko,
• maʻi kūlohelohe i ke ʻano o ka ʻōpū palupalu, hōʻeha a me ka ʻeha.

ʻO ka maʻa maʻamau o kēlā me kēia lā he 500 mg (no ka maʻi diabetes, hāʻawi i ka 250 mg i kēlā me kēia lā). ʻO ka papa o ka lāʻau me Idrinol mai 4 a 6 wiki.

ʻAʻole ʻai ka ʻai i ka ʻai o ka helu o nā mea ikaika o ka lāʻau.

He hiʻohiʻona Mildronate

Ua kuhikuhi ʻia ʻo Mildronate i nā maʻi me nā kiʻi haukapila e like me kēia:

• maʻi maʻi coronary
• nāwaliwali o ka puʻuwai
• cardiomyopathy plg,
• kūlana preinfarction
• nā hoʻopiʻi post-infarction,
• myocardial infarction
• ulia pōpilikia maʻamau,
• ka hemahema cerebrovascular,
• haʻalele kino maʻi
• retorr a or vitreous hemorrhage,
• ʻephlelo huna
• maʻi maʻi pāhāpeka
• ʻOiaʻiʻo
• diabetic a me hypertensive retinopathies,
• ka luhi ana i ke kino.

Hoʻohana ʻia ka lāʻau lapaʻau ma ka mālama kino o ka maʻi maʻi.

Hoʻohana ʻia ka lāʻau lapaʻau e hōʻemi i ka hopena o ka hōʻino o ke kūlana o ka mea maʻi, a ʻaʻole no ka mālama ʻana i nā maʻi i ke ʻano o ka maʻi nui.

Mālama maikaʻi ka lāʻau lapaʻau i ka hoʻihoʻi ʻana i ka ikaika ma hope o ka hoʻoulu ʻana i ke kino a hoʻonui i nā kū i ke kaumaha. Hoʻohana ka poʻe paani i nā lāʻau lapaʻau e hoʻihoʻi i ka ikaika ma waena o nā hana ikaika.

Eia kekahi, hoʻomaikaʻi ʻo Mildronate a hoʻoponopono i ka hāʻawi o ke koko i ka ʻina o ka maka; inā ke ʻano kūlohelohe o ka lolo, hoʻomaikaʻi i ke kūlana o ka mea maʻi.

ʻO ka hopena cardioprotective o Mildronate i ka mālama ʻana i ka maʻi coronary a me ka hopena o ka pōʻino i ka ʻōpū o ka puʻuwai e like me kēia:

• hoʻonui i ka hoʻolaha o ka puʻuwai naʻau i ke kaumaha,
• ka hōʻemi ʻana o ka maka necrosis,
• ka hoʻomaikaʻi ʻana i ka kaʻe o ke koko i ka wahi i hoʻopili ʻia,
• ka hōʻemi ʻana i ka lōʻihi o ka manawa hoʻoponopono.

I nā poʻe maʻi e hōʻeha nei i nā maʻi puʻuwai lōʻihi, hiki i ka lāʻau lapaʻau ke hōʻemi i ka nui o ka hoʻouluʻana o ka angina.

He nui nā contraindications i ka lāʻau. ʻAʻole ʻae ʻia ia e ʻae i nā helu i hiki mai i nā maʻi:

• hapai
• i nā makuahine hānai
• Nā poʻe ma lalo o 18
• loaʻa mai ka hoʻonaninani ʻana i ke koʻikoʻi intracranial.

Hoʻomaʻamaʻa ʻia ka mālama ʻana i kekahi kanaka me ka maʻi hema a i ʻole ka hana a ka pūpū.

ʻO nā hopena koʻikoʻi nā ʻano:

• ka hanaʻole ʻana o ka kūwaho,
• poʻomanaʻo
• lele i loko o ke koko
• tachycardia
• psychomotor agitation,
• ka māla ʻana
• nā hopena kūlohelohe.

ʻO nā hopena waiwai nui o Mildronate e loaʻa: ka hoʻopulapula o ka hana o ka digestive tract, headaches.

Ma kahi o ka hōʻike o nā hopena maikaʻiʻole, pono ʻoe e kāpae i ke ʻano o ke ʻano me ka lāʻau lapaʻau a kūkākūkā me kahi kauka.

ʻAʻole hopena ka lāʻau i ka hopena o ka hopena, no laila, ʻae ʻia kāna hoʻohana a me nā kaʻa kaʻa ke ʻae ʻia.

Hoʻohālikelike o Idrinol a me Mildronate

Ua kuhikuhi ʻia nā lāʻau pono e hoʻolalelale i nā kaʻina metabolic i loko o ke kino, hoʻonui i ka hana pono a me ka ikaika. Hoʻohana ʻia lākou e like me ka cardioprotector e hōʻemi i nā hōʻailona hōʻoluʻolu i ka hōʻole ʻana i ka wai inu.

Hoʻoloka ka nui o nā lāʻau lapaʻau, ʻokoʻa ka hopena ma waena o lākou.

ʻO wai ka mea maikaʻi - Meldonium a me Mildronate?

ʻAʻole hiki ke pane ʻia kēia nīnau, no ka mea he melisone ke ʻano ikaika o Mildronate. ʻO kēia ka lāʻau lapaʻau. Eia nō naʻe, ʻo Mildronate ka lāʻau kanu mua, a ʻo Meldonium kahi mea i hana ʻia e like me ke kumu o ka kumu. No laila, ʻoi aku ka maikaʻi o ke koho iā Mildronate.

ʻLelo a nā kauka e pili ana i nā Meldonia a me Mildronate

Eugene, 49 mau makahiki, cardiologist, Vitebsk: “Ma pinepine ke hoʻohana iā Mildonium a me Mildronate i nā maʻi me nā maʻi maʻi. ʻAʻole hiki i kēia mau lāʻau ke hōʻoli i nā hopena ʻaoʻao. Mālama kā lākou mea koʻikoʻi i ke kahe o ke koko, no laila ua hala nā poʻo. "

ʻO Margarita, he 55 makahiki, ʻo ia nā mea lapaʻau, ʻo Samara: "Meldonium a me Mildronate he mau analogue, no laila hāʻawi pinepine wau iā lākou i kaʻu hana. Ma hope o kahi papa lāʻau, ʻoluʻolu kekahi, a ʻoi aku ka loaʻa ʻana o nā ʻinoʻino. Akā e aʻo ʻia nā poʻe me ka tachycardia e lawe i nā lāʻau lapaʻau me ka mālama aka a ma ka palena liʻiliʻi. ”

Nā Hōʻike Hoʻomaʻi

Ekaterina, 41 makahiki, Moscow: “Ua hana ikaika wau i nā haʻuki, no laila ua ʻōlelo aku ka mea aʻoaʻo me ka hoʻohana ʻana i ka lāʻau Mildronate. Hoʻoikaika ia i ka ahonui, e hiki ai iā ʻoe ke hoʻomaʻamaʻa lōʻihi loa. Ua lawe au i kahi mahina a hauʻoli i ka hopena, no ka mea, ua mau ʻole koʻu luhi. ”

ʻO Valentina, 44 makahiki, ʻo Voronezh: “Ua hoʻopilikia wau mai ka dystonia vascular i koʻu ola āpau. I ka wā hopohopo, hoʻomaka ka huki a puka mai ka dyspnea. Ua kauoha kekahi hoa aloha i ka lāʻau Meldonium. Ma hope o ke ʻano o ka mālama ʻana, lilo wau i ʻoluʻolu a ʻaʻole wau i ʻano nui i nā kūlana kaumaha loa. "

ʻLelo a nā kauka e pili ana i ka Idrinol a me Mildronate

Sergey, 44 makahiki, psychiatrist, Vladivostok

ʻO Idrinol kahi antihypoxant, kahi mea hoʻohālike o Mildronate, kahi hopena hōʻeha maikaʻi i nā mea ʻokika ma ke ʻano intravenously a me nā capsules. Hoʻopau i kahi kokoke i nā pathology vascular (maʻi naʻau coronary, angina pectoris, cerebral arteriosclerosis, nā ʻano encephalopathies). I nā hopena asthenic e hāʻawi i kahi hopena psycho-energetic. ʻO ka hopena hōʻoluʻolu ʻoluʻolu i loko o nā poʻe ma ke ʻano o nā meaʻai me desynchronosis (hoʻohuli ʻia e nā kauka).

ʻO ka lāʻau maikaʻi loa no ka monotherapy a ma ke ʻano o ka mālama hoʻohui ʻana o ka pathology vascular a me ka psychosomatic, i ka mālama ʻana i ka ulana i ʻoi aku ka maikaʻi ma mua o Mexidol.

Maria, 33 makahiki, cardiologist, Moscow

Hoʻoluʻolu me ka hopena o Mildronate. Ma hope o 10 mau lā o ka hoʻopili ʻana, ʻike ka poʻe maʻi i ka ulu ʻana o ka ikaika, hoʻonui nui ʻia. ʻO kahi lāʻau lapaʻau maikaʻi, ʻōlelo au i ka hana. Ua hana wau me kēia lāʻau lapaʻau no 6 makahiki. Hoʻohana wau i ka hoʻokele intravenous, intramuscular a ma ka ʻōlelo maʻamau. Kāleka - 500 mg. ʻO nā māhini nui: ka maʻi naʻau coronary, myocardial dystrophy, cardiosclerosis post-infarction, VVD, HIGM, nā maʻi dystrophic o nā kino o ka ʻike.

Nadezhda, 62 mau makahiki, neurologist, St.

Ma kaʻu hoʻomaʻamaʻa ʻana, haʻi wau i ka lāʻau lapaʻau Mildronate no ka neurasthenia, ke kuʻihui a me ka noʻonoʻo nui, a me ka nānā pū ʻana i nā maʻi ʻano like ʻole o ka kaila o ke kaila o ke kaila o ka lolo. Hoʻomaka koke ka lāʻau lapaʻau i ka hopena maikaʻi, no nā mea maʻi ma mua o 65 mau makahiki o kaʻu makahiki, ke kuhikuhi nei wau iā ia wale nō ma hope o kahi hoʻokolohua hou e kāpae i ka hopena o nā hoʻopiʻi.